Michael Weisnagel

Michael Weisnagel, Director, Commercialization & Marketing


Michael Weisnagel is a healthcare commercialization executive with extensive experience helping innovative health technology companies navigate market entry, commercialization, adoption, and scale within Canada and international healthcare markets.

His career spans healthcare IT, medical technology, pharmaceuticals, and health system innovation, with a consistent focus on bridging the gap between promising innovation and sustainable market adoption. Michael has worked with emerging companies, global organizations, investors, healthcare providers, and innovation ecosystems to accelerate commercialization while reducing risk for innovators, healthcare systems, and funding partners.

At EXCITE International, Michael's focus extends beyond technology assessment to building a sustainable commercialization engine that strengthens EXCITE's role as a trusted catalyst for healthcare innovation. His vision is to position EXCITE as the leading global authority for evidence generation, commercialization readiness, and market adoption of transformative health technologies.

Michael Weisnagel, EXCITE International Board Member

Michael Weisnagel

Director, Commercialization & Marketing, EXCITE International

Work with us. EXCITE International can assist you in facilitating multi-jurisdictional clinical trials through its partnership with government, clinical experts, methodology centres and health system decision makers.